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Background: Diabetic peripheral arterial disease is the main cause of lower limb amputation in patients with
diabetes. To summarize the technique and experiences and evaluate the clinical effects of blood vessel intervention
operation on diabetic peripheral artery disease.
Methods: 81 patients with diabetic peripheral artery disease from October 2007 to September 2011, 81 cases of
the observation group were treated by balloon PTA. By adopting the Seldinger puncture technology, intubation
was placed into a cobra catheter or a pig tail artery catheter and directed to the ipsilateral lower extremity artery. A
guidewire was used to reach the lesion part of patients and a long balloon with a diameter of 4–6 mm was used
to expand the artery with a pressure of 6–10 atm.
Results: 81 patients in the observation group received the PTA surgery. The technical succesful rate was 100%, no
complication happened. The skin temperature increased after treatment. The blood supply improved significantly.
The pulsation of the foot dorsal artery was strengthened. The numbness and pain symptoms were moderated
significantly. We observed better results in the observation group in lower limb vessel diameter and foot ulceration
healing. None of the patients received amputation surgery. Its short-term effects were satisfactory.
Conclusion: PTA is a feasible technique for diabetic peripheral artery disease. It has great clinical significance in
treating diabetic peripheral arterial disease. Although its short-term effects is satisfactory, the long-term effects is
necessary for follow up.
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Peripheral arterial disease (PAD) is a group of disorders
characterized by narrowing or occlusion of the arteries
resulting in gradual reduction of blood supply to the
limbs. PAD may be asymptomatic until it reaches an ad-
vanced stage [1] Diabetic peripheral arterial disease is
the main cause of lower limb amputation in patients
with diabetes. Patients with diabetic peripathic arterial
disease are at high risk of increased morbidity and mor-
tality from cardiovascular diseases. Factors, such as age
and the duration of the disease, will increase its inci-
dence and risk of death, and uncontrolled infection often
leads to amputation [2,3] worldwide and that patients* Correspondence: tianailing70@126.com; snf-701207@163.com
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reproduction in any medium, provided the orwith diabetes are at excess risk of developing PAD, the
implications of the problem are enormous [4].
The Hoorn study found that the prevalence of ABI < 0.9
in individuals with normal glucose tolerance was 7%
and increased to 20.9% in patients with diabetes, while a
pilot study found a prevalence of asymptomatic PAD of
33% [5,6].
In the Rochester study, the cumulative incidence of
PAD was 15% 10 years after the diagnosis of DM, which
increased to 45% 20 years later [7]. Patients with dia-
betes have increased risk of lower-extremity amputations
in comparison with non-diabetic subjects and the sever-
ity of PAD in DM assessed angiographically has been
associated with major amputations [8,9]. The 5-year mor-
tality in patients with diabetes and critical limb ischaemia
is 30% [10].
The aims in the management of the patients with dia-
betic peripathic arterial disease are to improve symptoms. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Since traditional medicine conservative treatment has poor
effects and vascular bypass surgery often causes large
trauma, new treatments such as percutaneous transluminal
angioplasty (PTA) and luminal stenting surgery have
emerged in recent years. Both of these are endovascular
treatments. Classically, the indications for a PTA in
diabetic peripheral arterial disease are disabling claudi-
cation affecting quality of life after medical therapy has
failed to improve symptoms, and critical limb ischae-
mia symptoms. With smaller surgical trauma and cer-
tain curative effect, these procedures have become the
hotspots in the field of treatment of diabetic peripheral
arterial disease.
From 2007 to 2011, endovascular treatments were used
in 119 lower extremities of 81 patients with diabetes. The




From October 2007 to September 2011, 81 hospitalized
patients with diabetic lower extremity arterial disease
were chosen for the study. The patients had a indication,
for example intermittent limping, rest pain and ischemic
ulcer. Among them were 48 males and 33 females with
ages ranging from 46 to 82 years old. The duration of
diabetes varied from 6 to 26 years and the duration of
diabetic peripheral arterial disease varied from 2 to
21 years. Patients were diagnosed with diabetic peripheral
arterial disease as their lower extremity arterial ultra-
sound examination showed different degrees of segmen-
tal stenosis and block as well as foot lesions. A total of 43
patients were complicated with 59 diabetic foot ulcers,
and they were segregated according to the Wagner classi-
fication [11]: 14 at level 1, 24 at level 2, 17 at level 3, and
4 at level 4.
There were 13 patients who also had cerebrovascular
disease, 17 patients who also had coronary heart disease,
21 patients who also had hypertension, 15 patients who
also had coronary heart disease and hypertension simul-
taneously, and 15 patients who also had peripheral neur-
opathy. All of their digital subtraction angiography (DSA)
showed segmental stenosis (>50%) or short segmental
lesions. All patients in the observation group received per-
cutaneous transluminal angioplasty or luminal stenting
surgery, and all were treated successfully. All patients
were screened for the absence of anemia, chronic cor
pulmonale, and other diseases which can cause hemo-
dynamic changes.
Statements
We confirmed that our study was approved by ethics
committee of Qilu Hospital of Shandong University. Weconfirmed that informed consent was obtained from all
study participants for our inclusion in our study.
Therapeutic method
The blood sugar of patients were controlled in a stable
range after some diet and drug therapy (Blood-fasting
sugar 3.9mmoL/L-6.1 mmoL/L). The groups were treated
with improving microcirculation drugs (e.g., Ligustrazine
Hydrochloride for injection, Xingding solution and So-
dium Aescinate for injection), neurotrophic drugs (e.g.,
Mecobalamin tablets), and local dressing.
The surgical operation was performed using a large
x-ray machine (Siemens, Germany). Eleven patients se-
lected the antegrade puncture, 67 patients opted for the
contralateral femoral artery puncture, and 3 patients chose
the humerus artery puncture. By adopting the Seldinger
puncture technology, intubation was placed into a cobra
catheter or a pig tail artery catheter and directed to the ip-
silateral lower extremity artery. Then, a step-by-step DSA
was used to take angiography for each segmental ar-
tery separately.
For patients with segmental stenosis or short segmental
lesions in the superficial femoral artery or femoral pro-
found artery, a 0.035 inch stiff type guidewire was used
to reach the lesion part. A long balloon with a diameter
of 4–6 mm was used to expand the artery with a pressure
of 6–10 atm. If the stenosis is more serious or if the ar-
tery retracted after expansion, it was placed in a self-
expandable stent of an appropriate model (Cordis, USA).
For patients with infrapopliteal artery stenosis, a 0.014
inch stiff type guidewire was used. This was designed for
tibial and peroneal artery disease. A deep long balloon
with a major axis of 120 mm was used to get through all
infrapopliteal arteries, including the most distant plantar
arteries (Figures 1, 2, 3 and 4).
To prevent postoperative arterial thrombosis, a regular
anticoagulant therapy was adopted: Clopidogrel Hydro-
gensulfate Tablets 50 mg, every day × 1, per os for six
months; Bayaspirin 100 mg, every day × 1, for long-term
use. In addition, symptomatic supportive treatment, such
as blood sugar control, infection prevention, improving
microcirculation, and local dressing, should be provided
after surgery. Six months later, another vascular color
Doppler ultrasound examination was performed.
Evaluation indexes
Clinical symptoms, vascular ultrasonic changes, and foot
ulcer healing conditions were observed and evalu-
ated. The following observations have been concluded:
a) Clinical symptoms changes included skin color, pain,
temperature sensation, and pulsation of foot dorsal ar-
tery; b) The lower extremity vascular color Doppler
ultrasound examination showed the changes in arterial
diameter; c) The size, secretion, and wound granulomas
Figure 2 The arteriography picture in the operating (The
sacculus was expanding the anterior tibial artery).
Figure 1 The arteriography picture prior treatment (The
obliteration of anterior tibial artery and arteria fibularis).
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after the surgery.
Statistical methods
For this study, SPSS 11.0 statistics software analysis tech-
nology was adopted. The research was made with a two-
factor factorial design. The result can be analyzed with
variance analysis.
Results
In the observation group, 81 patients received the PTA
surgery. Out of the 81 patients, 35 added a self-expandable
stent (Cordis Company) after balloon expanded. This
resulted to a success rate of 100%.
For patients in the observation group, the skin temp-
erature increased after treatment. The blood supply im-
proved significantly. The pulsation of the foot dorsal
artery was strengthened. The numbness and pain symp-
toms were moderated significantly. In all, its short-term
effects were satisfactory.
The vascular ultrasound results of the observation group
showed that the vascular diameters have increased signifi-
cantly compared with the data taken before treatment as
well as compared with the control group. It had an effi-
ciency rate of 100% (Table 1).
In the observation group, ten days after the treat-
ment, level 1 patients under the Wagner classificationhad the following results: 5 bloody vesicles in 14 limbs
healed completely, 4 in 9 superficial ulcerations healed,
and 5 had improved surrounding skin color and narrowed
ulcer surface. For level 2 patients, the inflammation was
reduced in 24 limbs. The purulent secretions were sig-
nificantly reduced as well, and ulcers started to grow
granulation tissues. For level 3 patients, the surrounding
skin began to grow and purulent secretions and vomica
were reduced in 17 limbs. For level 4 patients, wet and
dry gangrene wounds were reduced and some necrotic
tissues dropped off in 4 limbs. Thirty days after the treat-
ment, the patients from levels 1 and 2 had their ulcers
healed completely. For the patients from level 3, 14 ulcers
healed, other ulcers no longer produced purulent secre-
tions, the vomica became shallow, and the ulcer surface
was reduced significantly. For the patients from level 4,
the ulcer surface was reduced significantly, necrotic tis-
sues dropped off, and new granulation tissues started to
grow. Sixty days after treatment, all ulcers healed without
any amputation.
Figure 3 The arteriography picture in the operating (The
sacculus was expanding the arteria fibularis).
Figure 4 The arteriography picture post treatment (The
recanalization of anterior tibial artery and arteria fibularis).
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The observation group had no complications, such as
acute occlusion or distal vascular embolization. Four pa-
tients broke their anterior tibial artery or peroneal artery
during the surgery, but the swelling and pain disappeared
after application of cold compress, physical therapy, and
Hirudoid ointment treatment. During the follow-up within
one year to three and a half years, all patients did not get
serious ischemia symptoms in their lower extremities. The
patients who received infrapopliteal artery balloon expan-
sion surgery had a patency rate of more than 80%. More-
over, the limb ulcer had already healed, and the clinical
symptoms had disappeared. None of the patients received
amputation surgery.
Discussion
In the world, due to changes in the structure of people’s
diet, the incidence of diabetes has increased gradually
and so has incidences of lower extremity disability caused
by diabetic peripheral arterial disease. The Framingham
study showed that there was a 3.5- and 8.6-fold excess riskamong men and women, respectively, of developing PAD
in patients with DM [12].
Diabetic peripheral arterial disease is a characteris-
tic of arteriosclerosis of the lower extremity arteries.
It often involves several arteries of the double lower
extremities [13,14]. Patients with diabetic peripathic ar-
terial disease commonly show involvement of the arteries
below the knee, especially at the tibial and peroneal arter-
ies, and involvement of the profunda femoris [10]. It is
multi-seasonally distributed and most prevalent in the
tibial and peroneal arteries of the calf, including anterior
tibial artery, posterior tibial artery and peroneal artery.
Life style modifications are the first mode of therapy, and
most of the studies have shown physical exercise improves
exercise tolerance at least a doubling in walking distance
[15]. There is no conclusive evidence to suggest that opti-
mal glycaemic control lowers the risk of PAD [16]. The
management of dyslipidaemia in patients with diabetic per-
ipheral arterial disease is warranted and the primary aim is
LDL-cholesterol levels < 2.6 mmol⁄ l [17].
Due to the small diameter and the multi-branching of
the arteries, the conventional treatment method of bypass
Table 1 Comparison of diameter changes at the narrowest point of the lower extremity artery under vascular color
Doppler ultrasound examination before and after treatment
Time of therapy Arteria cruralis(mm) Popliteal artery(mm) Arteria dorsalis pedis(mm)
L R L R L R
prior treatment 7.11 ± 0.14 7.12 ± 0.15 5.14 ± 0.36 5.11 ± 0.26 1.22 ± 0.11 1.21±0.32
post treatment 7.68 ± 0.11 7.66 ± 0.41 5.70 ± 0.45 5.67 ± 0.42 1.75 ± 0.19 1.82±0.43
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Furthermore, there was a high rate of postoperative resten-
osis and reblock, which is why the long-term outcome is
not very satisfactory.
Therefore, with the constant updating of the treatment
technology and equipment, the application of percutan-
eous transluminal angioplasty and luminal stenting surgery
in the treatment of diabetes mellitus have caught the atten-
tion of surgeons at home and abroad. These techniques
can radically improve the treatment of diabetic lower ex-
tremity arterial disease [18,19].
Since 2005, our department has carried out clinical re-
search on endovascular treatment for diabetic peripheral
arterial disease. Up until now, 81 patients have been
treated. This study is currently in progress. The results
showed that the clinical symptoms, vascular ultrasonic,
and foot ulcer healing conditions of the observation
group had significantly improved after the treatment. In
contrast, the clinical symptoms, vascular ultrasonic, and
foot ulcer healing conditions of the control group had
no significant improvement after the treatment. There
were no significant differences between the two groups
before the treatment. Even if the observation group had
a significant improvement compared with the control
group after the treatment, all the above information
showed only that endovascular treatment has a satisfactory
short-term effect for diabetic lower extremity arterial dis-
ease. However, due to the limitation of the short follow-up
time and the inadequate number of patients, the long-term
efficacy of endovascular treatment remains unclear. It re-
quires a long-term accumulation of information from a
large sample.
Through this research, it can be concluded that endo-
vascular treatment for diabetic peripheral arterial disease
has many advantages: a) It has smaller chances of trauma
and a faster recovery speed. It can also provide an imme-
diate effect after the treatment; b) It has a high success
rate and a low mortality rate. The current success rate of
interventional therapy is up to 100%, while mortality rate
is almost 0; c) It has a high rate of limb salvage. The dia-
betic foot ulcers caused by hypoxia-ischemia of patients
who have undergone interventional treatment will grad-
ually heal with the recanalization of blood vessels. As
a result, the limb salvage rate was significantly higher
than before; d) It is a kind of repeatable treatment. With
a repeatable balloon dilatation, the restenosis of thelesion can be re-expanded with the same safety and ef-
fectiveness to improve the rate to save ischemic limbs;
e) The intervention requires only local anesthesia, which
has less side effects and is more suitable for elderly and
frail patients [20].
One reported that patients with DM develop more
symptomatic forms of PAD such as intermittent claudica-
tion, foot ulcers and critical limb ischaemia symptoms [21].
But in the follow-up, we found that patients who received
infrapopliteal artery balloon expansion surgery have
high restenosis rate, but the limb ulcer have healed,
and the clinical symptoms have disappeared. Thus, the
endovascular treatment for diabetic peripheral arterial dis-
ease could rapidly improve the blood supply and provide
time for the foot ulcer and sectional toe wound to heal.
With the gradual formation of restenosis, the collateral
compensatory circulation was also gradually established,
thereby greatly increasing the limb-salvage rate. These are
the clinical significance and value of the endovascular
treatment for diabetic peripheral arterial disease.
Because in the small diameter intravascular stent can
lead to the early thrombosis and late lumen lost, thus
affecting support long-term patency rate. It still have
considerable controversy for whether the infrapopliteal
arteries stented. At present scholars do not recommend
the infrapopliteal arteries conventional implant the drug-
uncoated stents, and bare metal stents is limited to postop-
erative failure cases of balloon expansion as a remedial
method. With the new technology and new method devel-
opment, some surgeon try to have drug-coated stents
in the infrapopliteal arteries. Our groups of patients of
infrapopliteal arteries had a good treatment effect after bal-
loon expansion and no vascular rupture cases, so there is
no implant any stents.
Conclusions
Diabetic peripheral arterial disease is the main cause of
lower limb amputation in patients with diabetes. We sum-
marized the technique and evaluated the clinical effects of
blood vessel intervention operation on diabetic peripheral
artery disease. 81 cases of the observation group were
treated by balloon PTA. We draw a conclusion that PTA is
a feasible technique for diabetic peripheral artery disease.
The endovascular treatment has a significant clinical effect
in treating diabetic peripheral arterial disease. It can obvi-
ously improve the limb-salvage rate and the quality of life
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safety, and fewer complications, it has great clinical signifi-
cance in treating diabetic peripheral arterial disease. Al-
though its short-term effects is satisfactory, the long-term
effects is necessary for follow up.
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